Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""HEPATITIS B"" wg kryterium: Temat


Starter badań:

Tytuł:
Seroreactivity of antibodies to hepatitis B core antigen among hepatitis B surface antigen-screened negative blood donors and its implications for blood safety in a resource-constrained country.
Autorzy:
Yu RT; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Punzalan KAP; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Bhatnagar S; Abbott Laboratories Singapore Pte Ltd., Singapore.
Lutero RB; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Chamen IMS; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Masangkay CB; Research Institute for Tropical Medicine, Muntinlupa City, Philippines.
Arcellana-Nuqui EY; National Council for Blood Services, Department of Health, Manila, Philippines.
Pokaż więcej
Źródło:
Vox sanguinis [Vox Sang] 2024 Mar; Vol. 119 (3), pp. 252-256. Date of Electronic Publication: 2024 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Core Antigens*
Hepatitis B*/diagnosis
Humans ; Hepatitis B Surface Antigens ; Blood Safety ; Blood Donors ; DNA, Viral ; Hepatitis B virus/genetics ; Hepatitis B Antibodies ; Immunoglobulin M
Czasopismo naukowe
Tytuł:
Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis.
Autorzy:
Geta M; Translational Medicine Program, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. .; Department of Medical Microbiology, School of Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. .
Yizengaw E; Department of Laboratory Science, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Manyazewal T; Translational Medicine Program, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
BMC pediatrics [BMC Pediatr] 2024 Feb 28; Vol. 24 (1), pp. 145. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Hepatitis B Vaccines*
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Child ; Humans ; Vaccine Efficacy ; Hepatitis B virus ; Hepatitis B Antibodies ; Ethiopia
Czasopismo naukowe
Tytuł:
Breakthrough infection by hepatitis B virus in a vaccinated blood donor: An emerging threat for transfusion safety in low-endemic countries?
Autorzy:
Blanco S; Fundación Banco Central de Sangre, Córdoba, Argentina.; Instituto de Virología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Castro GM; Instituto de Virología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.; Departamento Laboratorio Central, Ministerio de Salud de la Provincia de Córdoba, Córdoba, Argentina.
Sicilia PE; Instituto de Virología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Carrizo LH; Fundación Banco Central de Sangre, Córdoba, Argentina.
Gallego SV; Fundación Banco Central de Sangre, Córdoba, Argentina.; Instituto de Virología, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.; CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas), Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2024 Feb; Vol. 96 (2), pp. e29463.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hepatitis B virus*/genetics
Hepatitis B*/diagnosis
Hepatitis B*/prevention & control
Hepatitis B*/epidemiology
Male ; Humans ; Breakthrough Infections ; Blood Donors ; DNA, Viral/genetics ; Hepatitis B Surface Antigens ; Hepatitis B Core Antigens ; Hepatitis B Antibodies
Czasopismo naukowe
Tytuł:
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
Autorzy:
Kan K; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Wong DK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Hui RW; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.
Seto WK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Yuen MF; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Mak LY; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Jan; Vol. 39 (1), pp. 202-209. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*
Hepatitis B, Chronic*/drug therapy
Humans ; Chemokine CXCL10/therapeutic use ; DNA, Viral ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Interferon-gamma ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.
Autorzy:
Tsai YN; Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Wu JL; Department of Public Health, National Cheng Kung University, College of Medicine, Tainan, Taiwan.
Tseng CH; Division of Gastroenterology and Hepatology, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.
Chen TH; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Wu YL; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Chen CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Fang YJ; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yun-Lin, Taiwan.
Yang TH; Division of Gastroenterology, Department of Medicine, Lotung Poh-Ai Hospital, Yilan, Taiwan.
Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, CA, USA.; Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, CA, USA.
Lin JT; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Hsu YC; School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.; Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
Clinical and molecular hepatology [Clin Mol Hepatol] 2024 Jan; Vol. 30 (1), pp. 98-108. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Hepatitis B Core Antigens*
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Adult ; Humans ; Male ; Middle Aged ; Female ; Hepatitis B Surface Antigens ; Antiviral Agents/therapeutic use ; Hepatitis B e Antigens ; DNA, Viral ; Recurrence ; Hepatitis B virus/genetics
Czasopismo naukowe
Tytuł:
Efficient implementation of hepatitis B surface antigen confirmatory neutralization tests.
Autorzy:
Yonezawa H; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Tanaka S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Medical Oncology, Sapporo Medical University School of Medicine, Sapporo, Japan. Electronic address: .
Tanaka M; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kobayashi R; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan.
Takahashi S; Division of Laboratory Medicine, Sapporo Medical University Hospital, Sapporo, Japan; Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Jan; Vol. 30 (1), pp. 29-33. Date of Electronic Publication: 2023 Sep 09.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/diagnosis
Hepatitis B, Chronic*
Humans ; Female ; Hepatitis B Surface Antigens ; Neutralization Tests ; Retrospective Studies ; Serologic Tests/methods ; Hepatitis B virus ; DNA, Viral
Czasopismo naukowe
Tytuł:
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy.
Autorzy:
Zhao Q; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Liu H; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Tang L; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Wang F; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Tolufashe G; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Chang J; Baruch S. Blumberg Institute, Doylestown, PA, United States.
Guo JT; Baruch S. Blumberg Institute, Doylestown, PA, United States. Electronic address: .
Pokaż więcej
Źródło:
Antiviral research [Antiviral Res] 2024 Jan; Vol. 221, pp. 105782. Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*
Hepatitis C, Chronic*/drug therapy
Hepatitis B*/drug therapy
Liver Neoplasms*/drug therapy
Humans ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Interferon-alpha/therapeutic use ; DNA, Viral
Czasopismo naukowe
Tytuł:
PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation.
Autorzy:
Wang J; Peking University Ditan Teaching Hospital, Beijing 100015, China; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yuan X; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; The Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Wang Y; The Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Zhang Y; The Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Han M; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; The Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Lu H; Hebei Utu Pharmaceutical Company Ltd, Shijiazhuang, Hebei Province 052165, China.
Liu S; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; The Division of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Zhang Y; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Ge F; Department of Chinese Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Liu Y; Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China. Electronic address: .
Cheng J; Peking University Ditan Teaching Hospital, Beijing 100015, China; Hebei Utu Pharmaceutical Company Ltd, Shijiazhuang, Hebei Province 052165, China. Electronic address: .
Pokaż więcej
Źródło:
Virus research [Virus Res] 2024 Mar; Vol. 341, pp. 199326. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B virus*/genetics
Hepatitis B*
Animals ; Humans ; Hepatitis B Surface Antigens/genetics ; Hepatitis B Surface Antigens/metabolism ; Proteolysis ; Hepatitis B Core Antigens/metabolism ; DNA, Viral/genetics ; DNA, Viral/metabolism ; Proteasome Endopeptidase Complex/metabolism ; Hep G2 Cells ; Viral Regulatory and Accessory Proteins/genetics ; DNA, Circular/metabolism ; Virus Replication/genetics ; RNA/metabolism ; Ubiquitins/genetics
Czasopismo naukowe
Tytuł:
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real-world data.
Autorzy:
Qin W; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Shao L; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.; Blood Purification Center, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Wang J; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Zhang H; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Wang Y; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Zhang X; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.; Department of Health Inspection and Quarantine, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Xie S; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Pan F; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Cheng K; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Ma L; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Chen Y; Department of Expanded Program on Immunization, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Song J; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Gao D; Microbiology Laboratory, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Chen Z; Microbiology Laboratory, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Yang W; Microbiology Laboratory, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Zhu R; Microbiology Laboratory, Lu'an Municipal Center for Disease Control and Prevention, Lu'an, Anhui, China.
Su H; Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2024 Mar; Vol. 31 (3), pp. 143-150. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Premature Birth*/epidemiology
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Phenylbutyrates*
Infant ; Female ; Child ; Infant, Newborn ; Humans ; Hepatitis B Surface Antigens ; Birth Weight ; Infant, Premature ; Retrospective Studies ; Follow-Up Studies ; Vaccination ; Hepatitis B Vaccines ; Hepatitis B Antibodies
Czasopismo naukowe
Tytuł:
Hepatitis delta in HIV/hepatitis B coinfection: A call for action.
Autorzy:
Celik D; Department of Infectious Diseases and Clinical Microbiology, Tepecik Education and Research Hospital, University of Health Sciences, Izmir, Turkey.; Department of Medicine I, University Hospital Bonn, Bonn, Germany.
van Bremen K; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany.
Breitschwerdt S; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany.
Elamouri F; Medical School Hamburg, Hamburg, Germany.
Swan T; GlobalHealth Consultant, Barcelona, Spain.
Boesecke C; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany.
Rockstroh JK; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), Partner-site Cologne-Bonn, Bonn, Germany.
Ingiliz P; Hepatology Department, Henri-Mondor University Hospital, Créteil, France.
Pokaż więcej
Źródło:
HIV medicine [HIV Med] 2024 Mar; Vol. 25 (3), pp. 319-321. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
Coinfection*
Hepatitis B*/complications
Hepatitis B, Chronic*/complications
Humans ; Hepatitis Delta Virus ; Hepatitis B virus ; Hepatitis B Surface Antigens
Czasopismo naukowe
Tytuł:
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study.
Autorzy:
Feliu-Prius A; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Barreira-Díaz A; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Rando A; Liver Pathology Laboratory, Microbiology and Biochemistry Department, Vall d'Hebron Clinical Laboratories, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Vargas-Accarino E; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Palom A; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Vico-Romero J; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ruiz-Cobo JC; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Riveiro-Barciela M; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Rodriguez-Frias F; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.; Liver Pathology Laboratory, Microbiology and Biochemistry Department, Vall d'Hebron Clinical Laboratories, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Esteban R; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Buti M; Medicine Department, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Liver Diseases Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Mar; Vol. 44 (3), pp. 706-714. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/epidemiology
Hepatitis B, Chronic*
Male ; Humans ; Hepatitis B Surface Antigens ; Retrospective Studies ; Hepatitis B virus
Czasopismo naukowe
Tytuł:
Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg.
Autorzy:
Gu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Li S; Liver Disease Center, Hunan Children's Hospital, Changsha, 410000, China.
Yao Z; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Lai X; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Yang M; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Xu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Peng S; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Feb 20; Vol. 22 (1), pp. 77. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*/therapeutic use
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Child ; Humans ; Child, Preschool ; Hepatitis B e Antigens/therapeutic use ; Retrospective Studies ; Hepatitis B virus ; Treatment Outcome ; Hepatitis B Antibodies/therapeutic use ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Distribution and Clinical Significance of Hepatitis B virus A1762T/G1764A Double Mutation in Chronic Hepatitis B Patients: A Cross-Sectional Study.
Autorzy:
Changsri K; Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Thailand.
Duangchanda T; Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Thailand.
Soimanee T; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Thailand.
Fuckpo W; Medical Technology laboratory section, Thammasat University Hospital, Pathum Thani, Thailand.
Pipatsatitpong D; Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.
Akekawatchai C; Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.; Thammasat University Research Unit in Diagnostic Molecular Biology of Chronic Diseases related to Cancer (DMB-CDC), Thailand.
Pokaż więcej
Źródło:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Feb 01; Vol. 25 (2), pp. 371-377. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B, Chronic*/genetics
Hepatitis B, Chronic*/complications
Carcinoma, Hepatocellular*
Liver Neoplasms*
Hepatitis B*
Humans ; Hepatitis B virus/genetics ; Cross-Sectional Studies ; alpha-Fetoproteins ; Hepatitis B Surface Antigens/genetics ; Hepatitis B e Antigens/genetics ; Clinical Relevance ; DNA, Viral/genetics ; Mutation ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/genetics ; Liver Cirrhosis/complications ; Genotype
Czasopismo naukowe
Tytuł:
Correlation analysis of hepatic steatosis and hepatitis B virus: a cross-sectional study.
Autorzy:
Yi S; Department of Infectious Disease and Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Ren G; Department of Infectious Disease and Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhu Y; Department of Infectious Disease and Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. .
Cong Q; Department of Infectious Disease and Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Jan 19; Vol. 21 (1), pp. 22. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B, Chronic*
Hepatitis B*
Humans ; Hepatitis B virus/genetics ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Cross-Sectional Studies ; DNA, Viral
Czasopismo naukowe
Tytuł:
Identification of associated risk factors for serological distribution of hepatitis B virus via machine learning models.
Autorzy:
Yao N; Department of Health Statistics, College of Preventive Medicine, Army Medical University, NO.30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China.; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Liu Y; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Xu J; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Wang Q; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Zhou Q; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Wang Y; Chongqing Center for Disease Control and Prevention, NO.8 Changjiang 2nd Street, Yuzhong District, Chongqing, 400042, China.
Yi D; Department of Health Statistics, College of Preventive Medicine, Army Medical University, NO.30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .
Wu Y; Department of Health Statistics, College of Preventive Medicine, Army Medical University, NO.30 Gaotanyan Street, Shapingba District, Chongqing, 400038, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 09; Vol. 24 (1), pp. 66. Date of Electronic Publication: 2024 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/epidemiology
Hepatitis B, Chronic*/epidemiology
Adult ; Humans ; Hepatitis B virus ; Hepatitis B Surface Antigens ; Seroepidemiologic Studies ; Risk Factors ; Hepatitis B Antibodies ; Machine Learning
Czasopismo naukowe
Tytuł:
Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses.
Autorzy:
Qiu J; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Zhang S; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Feng Y; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Su X; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Cai J; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Chen S; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Liu J; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Huang S; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Huang H; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Zhu S; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Wen H; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Li J; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Yan H; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Diao Z; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.
Liang X; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.; Jinan University-BioKangtai Vaccine Institute, Jinan University, Shenzhen, China.
Zeng F; Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, PR China.; Jinan University-BioKangtai Vaccine Institute, Jinan University, Shenzhen, China.
Pokaż więcej
Źródło:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 69-81. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B Vaccines*/adverse effects
Hepatitis B*/prevention & control
Humans ; Hepatitis B Surface Antigens ; Hepatitis B Antibodies ; Vaccination ; Hepatitis B virus ; Adjuvants, Immunologic ; Obesity
Czasopismo naukowe
Tytuł:
Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT Signaling.
Autorzy:
Ye Y; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Fu Y; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Lin C; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Shen Y; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Yu Q; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Yao X; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Huang Q; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Liu C; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Zeng Y; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Chen T; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Clinical Laboratory Diagnostics, The First Clinical College, Fujian Medical University, Fuzhou, China.
Wu S; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Xun Z; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Electronic address: .
Ou Q; Department of Laboratory Medicine, Gene Diagnosis Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Fujian Clinical Research Center for Clinical Immunology Laboratory Test, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Laboratory Medicine, National Reginal Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2024; Vol. 17 (2), pp. 219-235. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B virus*/genetics
Hepatitis B*/drug therapy
Mice ; Animals ; Humans ; Hepatitis B Surface Antigens ; Oncostatin M/pharmacology ; Hepatitis B e Antigens ; Interleukin-6 ; Mice, Inbred C57BL ; Signal Transduction ; Interferons ; Virus Replication
Czasopismo naukowe
Tytuł:
Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis.
Autorzy:
Wu HY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tsai JH; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
Wei MH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, BioMedical Park Hospital, HsinChu, Taiwan.
Chen CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tung CC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2024 Jan; Vol. 123 (1), pp. 88-97. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B, Chronic*
COVID-19*/prevention & control
Hepatitis B*
Humans ; COVID-19 Vaccines/adverse effects ; Hepatitis B virus/genetics ; Retrospective Studies ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; Hepatitis B e Antigens ; Alanine Transaminase ; Hepatitis B Surface Antigens ; DNA, Viral
Czasopismo naukowe
Tytuł:
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia.
Autorzy:
Bubonja-Šonje M; Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, Rijeka 51000, Croatia; Department of Clinical Microbiology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka 51000, Croatia. Electronic address: .
Peruč D; Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, Rijeka 51000, Croatia; Department of Clinical Microbiology, Teaching Institute of Public Health of Primorsko-Goranska County, Krešimirova 52a, Rijeka, Croatia.
Abram M; Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, Rijeka 51000, Croatia; Department of Clinical Microbiology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka 51000, Croatia.
Mohar-Vitezić B; Department of Microbiology and Parasitology, Faculty of Medicine, University of Rijeka, Braće Branchetta 20, Rijeka 51000, Croatia; Department of Clinical Microbiology, Clinical Hospital Centre Rijeka, Krešimirova 42, Rijeka 51000, Croatia.
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2024 Jan-Feb; Vol. 29 (1), pp. 101156. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B, Chronic*
Adult ; Humans ; Hepatitis B virus/genetics ; Hepatitis B Surface Antigens ; DNA, Viral/genetics ; Prevalence ; Croatia/epidemiology ; Hepatitis B Antibodies
Czasopismo naukowe
Tytuł:
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance.
Autorzy:
Suzuki F; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. .; Okinaka Memorial Institute for Medical Research, Tokyo, Japan. .
Hosaka T; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Suzuki Y; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Sezaki H; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Akuta N; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Fujiyama S; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Kawamura Y; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Saitoh S; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Arase Y; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Kobayashi M; Research Institute for Hepatology, Toranomon Branch Hospital, Kawasaki, Japan.
Kumada H; Department of Hepatology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Pokaż więcej
Źródło:
Journal of gastroenterology [J Gastroenterol] 2024 Jan; Vol. 59 (1), pp. 34-44. Date of Electronic Publication: 2023 Oct 14.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*
Hepatitis B, Chronic*/drug therapy
Humans ; Middle Aged ; Hepatitis B virus/genetics ; Antiviral Agents/therapeutic use ; DNA, Viral ; Recurrence ; Treatment Outcome ; Hepatitis B e Antigens
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies